| Ms Kathleen E Carey, MD | |
|
8500 Ne Oak Springs Farm Rd, Carlton, OR 97111-9586 | |
| (317) 806-8260 | |
| (317) 806-8296 |
| Full Name | Ms Kathleen E Carey |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 13 Years |
| Location | 8500 Ne Oak Springs Farm Rd, Carlton, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225337868 | NPI | - | NPPES |
| 300035074 | Medicaid | IN | |
| 349591 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 55361 (Arizona) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 010833274A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northwest Medical Center | Tucson, AZ | Hospital |
| Trios Health | Kennewick, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kennewick Radiology Group Pc | 9335230549 | 40 |
| Sonoran Radiology Ltd | 3375964505 | 367 |
News Archive
Scientists at the Carlos III University in Madrid (UC3M) are participating in a European research project designed to study tuberculosis treatments. The objective of the study is to improve diagnostic imaging technology in order to help develop new drugs to treat the disease.
Global ophthalmic company OptiMedica Corp. has announced the launch of its Catalys Precision Laser System in the United States, with the first patient cases performed by Drs. Mike and Paul Mann at the Mann Eye Institute in Houston.
Physician scientists at the Texas Heart Institute at St. Luke's Episcopal Hospital (THI at St. Luke's) have been awarded a grant of almost $1.5 million by the National Institutes of Health for research into treatments for patients with end-stage heart failure that would combine heart-assist devices and adult stem-cell treatments.
To gain a clearer picture of health and disease, scientists have now provided an independent reference for all human variation by looking through the evolutionary lens of our nearest relatives.
› Verified 5 days ago
| Entity Name | Sutter Valley Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174997407 PECOS PAC ID: 9830094515 Enrollment ID: O20101109001484 |
News Archive
Scientists at the Carlos III University in Madrid (UC3M) are participating in a European research project designed to study tuberculosis treatments. The objective of the study is to improve diagnostic imaging technology in order to help develop new drugs to treat the disease.
Global ophthalmic company OptiMedica Corp. has announced the launch of its Catalys Precision Laser System in the United States, with the first patient cases performed by Drs. Mike and Paul Mann at the Mann Eye Institute in Houston.
Physician scientists at the Texas Heart Institute at St. Luke's Episcopal Hospital (THI at St. Luke's) have been awarded a grant of almost $1.5 million by the National Institutes of Health for research into treatments for patients with end-stage heart failure that would combine heart-assist devices and adult stem-cell treatments.
To gain a clearer picture of health and disease, scientists have now provided an independent reference for all human variation by looking through the evolutionary lens of our nearest relatives.
› Verified 5 days ago
| Entity Name | Central Valley Imaging Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275523169 PECOS PAC ID: 8628064953 Enrollment ID: O20180213002000 |
News Archive
Scientists at the Carlos III University in Madrid (UC3M) are participating in a European research project designed to study tuberculosis treatments. The objective of the study is to improve diagnostic imaging technology in order to help develop new drugs to treat the disease.
Global ophthalmic company OptiMedica Corp. has announced the launch of its Catalys Precision Laser System in the United States, with the first patient cases performed by Drs. Mike and Paul Mann at the Mann Eye Institute in Houston.
Physician scientists at the Texas Heart Institute at St. Luke's Episcopal Hospital (THI at St. Luke's) have been awarded a grant of almost $1.5 million by the National Institutes of Health for research into treatments for patients with end-stage heart failure that would combine heart-assist devices and adult stem-cell treatments.
To gain a clearer picture of health and disease, scientists have now provided an independent reference for all human variation by looking through the evolutionary lens of our nearest relatives.
› Verified 5 days ago
| Entity Name | Los Robles Radiologic Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730157215 PECOS PAC ID: 0446319206 Enrollment ID: O20180712003325 |
News Archive
Scientists at the Carlos III University in Madrid (UC3M) are participating in a European research project designed to study tuberculosis treatments. The objective of the study is to improve diagnostic imaging technology in order to help develop new drugs to treat the disease.
Global ophthalmic company OptiMedica Corp. has announced the launch of its Catalys Precision Laser System in the United States, with the first patient cases performed by Drs. Mike and Paul Mann at the Mann Eye Institute in Houston.
Physician scientists at the Texas Heart Institute at St. Luke's Episcopal Hospital (THI at St. Luke's) have been awarded a grant of almost $1.5 million by the National Institutes of Health for research into treatments for patients with end-stage heart failure that would combine heart-assist devices and adult stem-cell treatments.
To gain a clearer picture of health and disease, scientists have now provided an independent reference for all human variation by looking through the evolutionary lens of our nearest relatives.
› Verified 5 days ago
| Entity Name | Kennewick Radiology Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679783534 PECOS PAC ID: 9335230549 Enrollment ID: O20190314002056 |
News Archive
Scientists at the Carlos III University in Madrid (UC3M) are participating in a European research project designed to study tuberculosis treatments. The objective of the study is to improve diagnostic imaging technology in order to help develop new drugs to treat the disease.
Global ophthalmic company OptiMedica Corp. has announced the launch of its Catalys Precision Laser System in the United States, with the first patient cases performed by Drs. Mike and Paul Mann at the Mann Eye Institute in Houston.
Physician scientists at the Texas Heart Institute at St. Luke's Episcopal Hospital (THI at St. Luke's) have been awarded a grant of almost $1.5 million by the National Institutes of Health for research into treatments for patients with end-stage heart failure that would combine heart-assist devices and adult stem-cell treatments.
To gain a clearer picture of health and disease, scientists have now provided an independent reference for all human variation by looking through the evolutionary lens of our nearest relatives.
› Verified 5 days ago
| Entity Name | Radiology Of Indiana P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992723829 PECOS PAC ID: 0648161430 Enrollment ID: O20200311001293 |
News Archive
Scientists at the Carlos III University in Madrid (UC3M) are participating in a European research project designed to study tuberculosis treatments. The objective of the study is to improve diagnostic imaging technology in order to help develop new drugs to treat the disease.
Global ophthalmic company OptiMedica Corp. has announced the launch of its Catalys Precision Laser System in the United States, with the first patient cases performed by Drs. Mike and Paul Mann at the Mann Eye Institute in Houston.
Physician scientists at the Texas Heart Institute at St. Luke's Episcopal Hospital (THI at St. Luke's) have been awarded a grant of almost $1.5 million by the National Institutes of Health for research into treatments for patients with end-stage heart failure that would combine heart-assist devices and adult stem-cell treatments.
To gain a clearer picture of health and disease, scientists have now provided an independent reference for all human variation by looking through the evolutionary lens of our nearest relatives.
› Verified 5 days ago
| Entity Name | Barden Thorwarth Daughtridge Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972597565 PECOS PAC ID: 6507756848 Enrollment ID: O20240126001612 |
News Archive
Scientists at the Carlos III University in Madrid (UC3M) are participating in a European research project designed to study tuberculosis treatments. The objective of the study is to improve diagnostic imaging technology in order to help develop new drugs to treat the disease.
Global ophthalmic company OptiMedica Corp. has announced the launch of its Catalys Precision Laser System in the United States, with the first patient cases performed by Drs. Mike and Paul Mann at the Mann Eye Institute in Houston.
Physician scientists at the Texas Heart Institute at St. Luke's Episcopal Hospital (THI at St. Luke's) have been awarded a grant of almost $1.5 million by the National Institutes of Health for research into treatments for patients with end-stage heart failure that would combine heart-assist devices and adult stem-cell treatments.
To gain a clearer picture of health and disease, scientists have now provided an independent reference for all human variation by looking through the evolutionary lens of our nearest relatives.
› Verified 5 days ago
| Entity Name | Focus Medical Imaging |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528299989 PECOS PAC ID: 6406999259 Enrollment ID: O20240213000455 |
News Archive
Scientists at the Carlos III University in Madrid (UC3M) are participating in a European research project designed to study tuberculosis treatments. The objective of the study is to improve diagnostic imaging technology in order to help develop new drugs to treat the disease.
Global ophthalmic company OptiMedica Corp. has announced the launch of its Catalys Precision Laser System in the United States, with the first patient cases performed by Drs. Mike and Paul Mann at the Mann Eye Institute in Houston.
Physician scientists at the Texas Heart Institute at St. Luke's Episcopal Hospital (THI at St. Luke's) have been awarded a grant of almost $1.5 million by the National Institutes of Health for research into treatments for patients with end-stage heart failure that would combine heart-assist devices and adult stem-cell treatments.
To gain a clearer picture of health and disease, scientists have now provided an independent reference for all human variation by looking through the evolutionary lens of our nearest relatives.
› Verified 5 days ago
| Entity Name | Placerville Radiology Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700847621 PECOS PAC ID: 0143382374 Enrollment ID: O20240216001888 |
News Archive
Scientists at the Carlos III University in Madrid (UC3M) are participating in a European research project designed to study tuberculosis treatments. The objective of the study is to improve diagnostic imaging technology in order to help develop new drugs to treat the disease.
Global ophthalmic company OptiMedica Corp. has announced the launch of its Catalys Precision Laser System in the United States, with the first patient cases performed by Drs. Mike and Paul Mann at the Mann Eye Institute in Houston.
Physician scientists at the Texas Heart Institute at St. Luke's Episcopal Hospital (THI at St. Luke's) have been awarded a grant of almost $1.5 million by the National Institutes of Health for research into treatments for patients with end-stage heart failure that would combine heart-assist devices and adult stem-cell treatments.
To gain a clearer picture of health and disease, scientists have now provided an independent reference for all human variation by looking through the evolutionary lens of our nearest relatives.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Kathleen E Carey, MD 9998 Crosspoint Blvd Ste 200, Indianapolis, IN 46256-3307 Ph: (317) 806-8285 | Ms Kathleen E Carey, MD 8500 Ne Oak Springs Farm Rd, Carlton, OR 97111-9586 Ph: (317) 806-8260 |
News Archive
Scientists at the Carlos III University in Madrid (UC3M) are participating in a European research project designed to study tuberculosis treatments. The objective of the study is to improve diagnostic imaging technology in order to help develop new drugs to treat the disease.
Global ophthalmic company OptiMedica Corp. has announced the launch of its Catalys Precision Laser System in the United States, with the first patient cases performed by Drs. Mike and Paul Mann at the Mann Eye Institute in Houston.
Physician scientists at the Texas Heart Institute at St. Luke's Episcopal Hospital (THI at St. Luke's) have been awarded a grant of almost $1.5 million by the National Institutes of Health for research into treatments for patients with end-stage heart failure that would combine heart-assist devices and adult stem-cell treatments.
To gain a clearer picture of health and disease, scientists have now provided an independent reference for all human variation by looking through the evolutionary lens of our nearest relatives.
› Verified 5 days ago